Ivo Abraham, PhD, RN, University of Arizona Cancer Center, analyzes the need for innovative risk-sharing models to promote biosimilar development and utilization.
The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to ...
5. "They're writing more inpatient orders and fewer observation visits, particularly for accounts over $2 million, as expected." As for how it's playing out with payers, Mr. Marks said HCA has seen a ...
NASHVILLE, Tenn., Sept. 18, 2024 /PRNewswire/ -- ProviderTrust, a leader in healthcare data and technology solutions, is excited to announce the launch of DynamicNPI™, an innovative connected data ...